Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Inventory (2020 - 2025)

Historic Inventory for Biofrontera (BFRI) over the last 6 years, with Q3 2025 value amounting to $4.3 million.

  • Biofrontera's Inventory fell 3366.53% to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year decrease of 3366.53%. This contributed to the annual value of $6.6 million for FY2024, which is 3907.22% down from last year.
  • As of Q3 2025, Biofrontera's Inventory stood at $4.3 million, which was down 3366.53% from $4.0 million recorded in Q2 2025.
  • Biofrontera's 5-year Inventory high stood at $16.1 million for Q3 2023, and its period low was $3.9 million during Q2 2024.
  • In the last 5 years, Biofrontera's Inventory had a median value of $6.6 million in 2024 and averaged $7.2 million.
  • As far as peak fluctuations go, Biofrontera's Inventory skyrocketed by 12222.84% in 2022, and later tumbled by 5938.51% in 2024.
  • Biofrontera's Inventory (Quarter) stood at $4.5 million in 2021, then surged by 60.79% to $7.2 million in 2022, then skyrocketed by 52.18% to $10.9 million in 2023, then plummeted by 39.07% to $6.6 million in 2024, then plummeted by 34.86% to $4.3 million in 2025.
  • Its Inventory stands at $4.3 million for Q3 2025, versus $4.0 million for Q2 2025 and $6.5 million for Q1 2025.